CRBRX
Price
$17.29
Change
+$0.18 (+1.05%)
Updated
Jun 22 closing price
Net Assets
2.75B
PMBCX
Price
$30.40
Change
-$0.31 (-1.01%)
Updated
Jun 22 closing price
Net Assets
23.7B
Interact to see
Advertisement

CRBRX vs PMBCX

CRBRX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
CRBRX vs. PMBCX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBRX is a Hold and PMBCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 23.7B vs. CRBRX (2.75B). CRBRX (0.00) and PMBCX (0.00) have matching dividends . CRBRX was incepted earlier than PMBCX: CRBRX (14 years) vs PMBCX (19 years). PMBCX (1.71) is less costly to investors than CRBRX (0.81). CRBRX is a more actively managed with annual turnover of: 78.00 vs. PMBCX (13.70). CRBRX has a lower initial minimum investment than PMBCX: CRBRX (0) vs PMBCX (1000). CRBRX annual gain was more profitable for investors over the last year : 33.26 vs. PMBCX (-14.29). CRBRX return over 5 years is better than : -5.60 vs. PMBCX (-10.62).
CRBRXPMBCXCRBRX / PMBCX
Total Expense Ratio0.791.7146%
Annual Report Gross Expense Ratio0.811.7147%
Fund Existence14 years19 years-
Gain YTD18.163-6.429-283%
Front LoadN/AN/A-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.75B23.7B12%
Annual Yield % from dividends0.000.00-
Returns for 1 year33.26-14.29-233%
Returns for 3 years53.598.75613%
Returns for 5 years-5.60-10.6253%
Returns for 10 years-1.5659.62-3%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NANR78.230.19
+0.24%
State Street® SPDR® S&P® NrthAmNtrlRsETF
USMV94.280.04
+0.04%
iShares MSCI USA Min Vol Factor ETF
UMAY37.89-0.07
-0.18%
Innovator U.S. Equity Ultra BffrETF™-May
TTXU33.76-0.17
-0.51%
Direxion Daily TecTop 5 Bull 2X ETF
PEX21.46-0.25
-1.14%
ProShares Global Listed Private Equity